A critical advance in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor protector protein is frequently disabled in several kinds of malignancies, causing https://thefairlist.com/story12225086/nanobodies-revive-p53-a-promising-approach-for-tumor-treatment